Search

Your search keyword '"Labotka, Richard"' showing total 7 results
Start Over Author "Labotka, Richard" Journal journal of clinical oncology
7 results on '"Labotka, Richard"'

1. Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Author

Richardson, Paul G., primary, Kumar, Shaji K., additional, Masszi, Tamás, additional, Grzasko, Norbert, additional, Bahlis, Nizar J., additional, Hansson, Markus, additional, Pour, Luděk, additional, Sandhu, Irwindeep, additional, Ganly, Peter, additional, Baker, Bartrum W., additional, Jackson, Sharon R., additional, Stoppa, Anne-Marie, additional, Gimsing, Peter, additional, Garderet, Laurent, additional, Touzeau, Cyrille, additional, Buadi, Francis K., additional, Laubach, Jacob P., additional, Cavo, Michele, additional, Darif, Mohamed, additional, Labotka, Richard, additional, Berg, Deborah, additional, and Moreau, Philippe, additional

Published
2021
Full Text
View/download PDF

2. Oral ixazomib-dexamethasone versus oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma (MM) patients: A global, multicenter, randomized, open-label, phase 2 trial.

Author

Dimopoulos, Meletios A., primary, Schjesvold, Fredrik, additional, Doronin, Vadim, additional, Vinogradova, Olga, additional, Quach, Hang, additional, Leleu, Xavier, additional, Yolanda, Gonzalez montes, additional, Ramasamy, Karthik, additional, Pompa, Alessandra, additional, Levin, Mark-David, additional, Lee, Cindy, additional, Mellqvist, Ulf-Henrik, additional, Fenk, Roland, additional, Sati, Hamdi, additional, Vorog, Alexander, additional, Labotka, Richard J., additional, Du, Jichang, additional, Darif, Mohamed, additional, and Kumar, Shaji, additional

Published
2021
Full Text
View/download PDF

3. Ixazomib vs placebo maintenance for newly diagnosed multiple myeloma (NDMM) patients not undergoing autologous stem cell transplant (ASCT): The phase III TOURMALINE-MM4 trial.

Author

Dimopoulos, Meletios A., primary, Spicka, Ivan, additional, Quach, Hang, additional, Oriol, Albert, additional, Hajek, Roman, additional, Garg, Mamta, additional, Beksac, Meral, additional, Bringhen, Sara, additional, Katodritou, Eirini, additional, Chng, Wee Joo, additional, Leleu, Xavier, additional, Iida, Shinsuke, additional, Mateos, Maria-Victoria, additional, Morgan, Gareth, additional, Vorog, Alexander, additional, Labotka, Richard, additional, Wang, Bingxia, additional, Palumbo, Antonio, additional, and Lonial, Sagar, additional

Published
2020
Full Text
View/download PDF

4. Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial.

Author

Dimopoulos, Meletios A., Špička, Ivan, Quach, Hang, Oriol, Albert, Hájek, Roman, Garg, Mamta, Beksac, Meral, Bringhen, Sara, Katodritou, Eirini, Chng, Wee-Joo, Leleu, Xavier, Iida, Shinsuke, Mateos, María-Victoria, Morgan, Gareth, Vorog, Alexander, Labotka, Richard, Wang, Bingxia, Palumbo, Antonio, Lonial, Sagar, and TOURMALINE-MM4 study group

Published
2020
Full Text
View/download PDF

5. Addressing unmet medical needs in maintenance treatment for newly diagnosed multiple myeloma (NDMM).

Author

Chng, Wee Joo, primary, Beksac, Meral, additional, Hajek, Roman, additional, Weisel, Katja, additional, Mateos, Maria-Victoria, additional, Spencer, Andrew, additional, Iida, Shinsuke, additional, de Farias, Danielle, additional, Labotka, Richard, additional, Skacel, Tomas, additional, Palumbo, Antonio, additional, Lonial, Sagar, additional, Kumar, Shaji, additional, and Dimopoulos, Meletios A., additional

Published
2018
Full Text
View/download PDF

6. Duration of second line treatment and survival in multiple myeloma.

Author

Hari, Parameswaran, primary, Tran, Linh Mai, additional, Yong, Candice, additional, Noga, Stephen J, additional, Farrelly, Eileen, additional, Raju, Aditya, additional, Seal, Brian S., additional, Labotka, Richard, additional, Blazer, Marlo, additional, Jhaveri, Mehul Rajesh, additional, and Romanus, Dorothy, additional

Published
2016
Full Text
View/download PDF

7. Two phase 3 studies of the oral proteasome inhibitor (PI) ixazomib for multiple myeloma (MM) in the maintenance setting: TOURMALINE-MM3, and -MM4.

Author

Palumbo, Antonio, primary, Morgan, Gareth John, additional, Rajkumar, S.Vincent, additional, Lonial, Sagar, additional, Chng, Wee Joo, additional, Iida, Shinsuke, additional, Mateos, María-Victoria, additional, Beksac, Meral, additional, Goldschmidt, Hartmut, additional, Labotka, Richard, additional, Suryanarayan, Kaveri, additional, di Bacco, Alessandra, additional, Liao, Eileen, additional, Wang, Bingxia, additional, and Dimopoulos, Meletios A., additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results